Literature DB >> 20864318

Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases--a multicentre study.

Yoon Soo Park1, Hyukmin Lee, Kkot Sil Lee, Seung Sik Hwang, Yong Kyun Cho, Hyo Youl Kim, Young Uh, Bum Sik Chin, Sang Hoon Han, Seok Hoon Jeong, Kyungwon Lee, June Myung Kim.   

Abstract

In this study, we investigated the risk factors for and carbapenem resistance mechanisms of extensively drug-resistant Acinetobacter baumannii (XDR-AB). Isolates of XDR-AB were collected from seven tertiary care hospitals in South Korea. A case-control study for risk factor analysis was performed and the presence of the metallo-β-lactamase (MBL) and OXA genes was examined. The control group consisted of adult inpatients receiving care from the same hospital. XDR-AB were isolated from 26 patients who were studied for risk factor analysis. Third-generation cephalosporin use [odds ratio (OR)=9.6, 95% confidence interval (CI) 1.3-171.3; P=0.02] and Acute Physiology and Chronic Health Evaluation (APACHE) II score (OR=1.2, 95% CI 1.1-1.5; P=0.004) were identified as risk factors for acquisition of XDR-AB. Pulsed-field gel electrophoresis (PFGE) showed clonal epidemic isolates in hospitals. MBLs were not detected, and all 30 XDR-AB isolates had upregulated OXA-type carbapenemase genes. These results suggest that third-generation cephalosporin use and disease severity are associated with XDR-AB acquisition amongst typical adult inpatients. This study also points to intrahospital spread of XDR-AB. Upregulated OXA-type carbapenemases are prevalent in XDR-AB founded in South Korean hospitals.
Copyright © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864318     DOI: 10.1016/j.ijantimicag.2010.06.049

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Types and prevalence of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in Northern Taiwan.

Authors:  Wen-Shyang Hsieh; Nai-Yu Wang; Jou-An Feng; Li-Chuan Weng; Hsueh-Hsia Wu
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

2.  Bacterial and antimicrobial susceptibility profile and the prevalence of sepsis among burn patients at the burn unit of Cipto Mangunkusumo Hospital.

Authors:  A Wardhana; R Djan; Z Halim
Journal:  Ann Burns Fire Disasters       Date:  2017-06-30

3.  Genomic and phenotypic characterization of the species Acinetobacter venetianus.

Authors:  Marco Fondi; Isabel Maida; Elena Perrin; Valerio Orlandini; Laura La Torre; Emanuele Bosi; Andrea Negroni; Giulio Zanaroli; Fabio Fava; Francesca Decorosi; Luciana Giovannetti; Carlo Viti; Mario Vaneechoutte; Lenie Dijkshoorn; Renato Fani
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

4.  Pandrug-resistant Acinetobacter Baumannii Infection Identified in a Non-intensive Care Unit Patient: A Case Study.

Authors:  Theodore Balfousias; Alexandros Apostolopoulos; Stavros Angelis; Dimitrios Filippou; Spyridon Maris
Journal:  Cureus       Date:  2019-12-07

5.  Defining bacterial species in the genomic era: insights from the genus Acinetobacter.

Authors:  Jacqueline Z-M Chan; Mihail R Halachev; Nicholas J Loman; Chrystala Constantinidou; Mark J Pallen
Journal:  BMC Microbiol       Date:  2012-12-23       Impact factor: 3.605

6.  Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: a case-control study.

Authors:  Ming-Chin Chan; Sheng-Kang Chiu; Po-Ren Hsueh; Ning-Chi Wang; Chih-Chien Wang; Chi-Tai Fang
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

7.  Extended-spectrum β-lactamase and carbapenemase production among burn and non-burn clinical isolates of Klebsiella pneumoniae.

Authors:  Fereshteh Eftekhar; Ziaeldin Naseh
Journal:  Iran J Microbiol       Date:  2015-06

8.  Epidemiological evaluation of an Acinetobacter baumannii outbreak observed at an intensive care unit.

Authors:  Tuğba K Atik; Bülent Atik; Osman Kilinç; Bayhan Bektöre; Hülya Duran; Burak M Selek; Nihan Ceken; Orhan Baylan; Mustafa Özyurt
Journal:  Saudi Med J       Date:  2018-08       Impact factor: 1.484

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.